Proton Pump Inhibitor MDL Motion Denied By Federal Judicial Panel

(February 2, 2017, 1:54 PM EST) -- WASHINGTON, D.C. — A federal judicial panel on Feb. 2 denied a motion to centralize 39 federal lawsuits alleging kidney injury from proton pump inhibitor (PPI) drugs because they involve four...
To view the full article, register now.